<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39380803</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1188-4169</ISSN><JournalIssue CitedMedium="Print"><Volume>50</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Canada communicable disease report = Releve des maladies transmissibles au Canada</Title><ISOAbbreviation>Can Commun Dis Rep</ISOAbbreviation></Journal><ArticleTitle>Evidence brief on facilitators, barriers and hesitancy of COVID-19 booster doses in Canada.</ArticleTitle><Pagination><StartPage>338</StartPage><EndPage>344</EndPage><MedlinePgn>338-344</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.14745/ccdr.v50i10a02</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Understanding the facilitators, barriers and hesitancy to accepting COVID-19 booster doses is important for encouraging recommended vaccination. This evidence brief summarizes literature on the intention to accept or reject COVID-19 vaccine booster doses and the factors associated with intention/uptake among individuals in Canada.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A database of COVID-19 literature established at the Public Health Agency of Canada was searched for articles referencing vaccination and knowledge, attitudes and behaviours towards COVID-19 boosters. A grey literature search of Canadian governmental and academic institutions was also conducted. Primary research conducted in Canada (n=21) and relevant systematic reviews of the global literature (n=8) were included in this evidence brief.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Intentions to get a booster dose in the general population have decreased between 2021-2023, with intentions varying across subpopulations. In Canada and within the global systematic reviews, facilitators, barriers and hesitancy were similar. Older age was the most common factor positively associated with intention/uptake of a booster, and the most common motivators were government/healthcare provider recommendations and helping to protect others. The main reasons for hesitancy were concerns about vaccine side effects and a lack of belief in the vaccine's efficacy.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Intentions to get a booster dose have decreased in Canada. Understanding the reasons for vaccine hesitancy and motivators for obtaining a booster can help guide future public health COVID-19 booster vaccination programs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Young</LastName><ForeName>Kaitlin M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>National Microbiology Laboratory, Public Health Agency of Canada, GuelphON.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corrin</LastName><ForeName>Tricia</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>National Microbiology Laboratory, Public Health Agency of Canada, GuelphON.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pussegoda</LastName><ForeName>Kusala</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>National Microbiology Laboratory, Public Health Agency of Canada, GuelphON.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baumeister</LastName><ForeName>Austyn</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>National Microbiology Laboratory, Public Health Agency of Canada, GuelphON.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waddell</LastName><ForeName>Lisa A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>National Microbiology Laboratory, Public Health Agency of Canada, GuelphON.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>Can Commun Dis Rep</MedlineTA><NlmUniqueID>9303729</NlmUniqueID><ISSNLinking>1188-4169</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">booster</Keyword><Keyword MajorTopicYN="N">vaccine acceptance</Keyword><Keyword MajorTopicYN="N">vaccine hesitancy</Keyword></KeywordList><CoiStatement>Competing interests None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>4</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39380803</ArticleId><ArticleId IdType="pmc">PMC11460581</ArticleId><ArticleId IdType="doi">10.14745/ccdr.v50i10a02</ArticleId><ArticleId IdType="pii">501002</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Public Health Agency of Canada. Canadian COVID-19 vaccination coverage report. Ottawa, ON: PHAC; 2024. [Accessed 2024 Mar 28]. https://health-infobase.canada.ca/covid-19/vaccination-coverage/</Citation></Reference><Reference><Citation>Government of Canada. An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI). Guidance on the use of COVID-19 vaccines during the fall of 2024. Ottawa, ON: Government of Canada; 2024. https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/national-advisory-committee-immunization-guidance-covid-19-vaccines-fall-2024.html</Citation></Reference><Reference><Citation>Corrin T, Ayache D, Baumeister A, Young K, Pussegoda K, Ahmad R, Waddell L. COVID-19 literature surveillance-A framework to manage the literature and support evidence-based decision-making on a rapidly evolving public health topic. Can Commun Dis Rep 2023;49(1):5–9. 10.14745/ccdr.v49i01a02</Citation><ArticleIdList><ArticleId IdType="doi">10.14745/ccdr.v49i01a02</ArticleId><ArticleId IdType="pmc">PMC9902036</ArticleId><ArticleId IdType="pubmed">36815866</ArticleId></ArticleIdList></Reference><Reference><Citation>Institut national de santé publique du Québec. Pandémie et vaccination - Résultats du 4 avril 2023. Québec, QC: INSPQ; 2023. https://www.inspq.qc.ca/covid-19/sondages-attitudes-comportements-quebecois/vaccination-4-avril-23</Citation></Reference><Reference><Citation>IPSOS. Four in Ten (40%) Canadians Do Not Intend to Get a COVID-19 Booster Vaccine Nor a Flu Shot. Vancouver, BC: IPSOS; 2023. https://www.ipsos.com/en-ca/four-in-ten-canadians-do-not-intend-get-covid-19-booster-vaccine-nor-flu-shot</Citation></Reference><Reference><Citation>Canadian Pharmacists Association. Vaccine intentions among Canadians August 2023 - OMNI Survey Results. 2023. https://www.pharmacists.ca/cpha-ca/assets/File/cpha-on-the-issues/CPhA-Cold-and-flu-season-survey-Aug2023-Release-deck.pdf</Citation></Reference><Reference><Citation>Reifferscheid L, Lee JS, MacDonald NE, Sadarangani M, Assi A, Lemaire-Paquette S, MacDonald SE. Transition to endemic: acceptance of additional COVID-19 vaccine doses among Canadian adults in a national cross-sectional survey. BMC Public Health 2022;22(1):1745. 10.1186/s12889-022-14025-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-022-14025-8</ArticleId><ArticleId IdType="pmc">PMC9473459</ArticleId><ArticleId IdType="pubmed">36104675</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazarus JV, Wyka K, White TM, Picchio CA, Gostin LO, Larson HJ, Rabin K, Ratzan SC, Kamarulzaman A, El-Mohandes A. A survey of COVID-19 vaccine acceptance across 23 countries in 2022. Nat Med 2023;29(2):366–75. 10.1038/s41591-022-02185-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02185-4</ArticleId><ArticleId IdType="pubmed">36624316</ArticleId></ArticleIdList></Reference><Reference><Citation>IPSOS. Global Attitudes on COVID-19 Vaccine Booster Shots. Vancouver, BC: IPSOS; 2021. https://www.ipsos.com/sites/default/files/ct/news/documents/2021-09/Global-attitudes-about-COVID-19-Vaccine-Booster-Shots-Sept%202021.pdf</Citation></Reference><Reference><Citation>IPSOS. Two in Three (67%) Canadians Believe that a Fully Vaccinated Population Won’t be Enough to Stop the Spread of Omicron. Vancouver, BC: IPSOS; 2022. https://www.ipsos.com/en-ca/news-polls/Two-Three-Canadians-Believe-Fully-Vaccinated-Population-Not-Enough-Stop-Omicron</Citation></Reference><Reference><Citation>IPSOS. Continued Strong Support for COVID-19 Boosters Among Canadians. Vancouver, BC: IPSOS; 2022. https://www.ipsos.com/en-ca/news-polls/continued-strong-support-for-boosters-among-canadians</Citation></Reference><Reference><Citation>Statistics Canada. Archived – Canadians’ health and COVID-19, by region, age, gender and other characteristics, inactive. Ottawa, ON: StatCan; 2022. [Accessed 2024 Mar 29]. https://www150.statcan.gc.ca/t1/tbl1/en/cv.action?pid=1310080901</Citation></Reference><Reference><Citation>Public Health Agency of Canada. The Impact of the Pandemic Experience on Future Vaccine-Related Intentions and Behaviours (2022). Ottawa, ON: PHAC; 2023. https://publications.gc.ca/collections/collection_2023/aspc-phac/H14-432-2023-eng.pdf</Citation></Reference><Reference><Citation>Nanos Research. A strong majority of Canadians say they will definitely take the COVID-19 vaccine booster shot when available. 2021. https://nanos.co/wp-content/uploads/2022/01/2021-2045-Globe-December-Populated-Report-Booster-with-Tabs.pdf</Citation></Reference><Reference><Citation>Nanos Research. Strong majority of Canadians show interest in getting a COVID-19 vaccination booster shot. 2021. https://nanos.co/wp-content/uploads/2021/10/2021-1981-CTV-September-Populated-report-Powerplay-with-tabs.pdf</Citation></Reference><Reference><Citation>Angus Reid Institute. Kids and COVID: Half of Canadian parents with children aged 5-11 ready to vaccinate their little ones ASAP. 2021. https://angusreid.org/wp-content/uploads/2021/10/2021.10.13_COVID_October_.pdf</Citation></Reference><Reference><Citation>Angus Reid Institute. COVID-19: Half want boosters ASAP, but two-in-five among vaccinated say they’re not sold on another shot. 2022. https://angusreid.org/covid-19-canada-booster-vaccine-skepticism/</Citation></Reference><Reference><Citation>Manitoba Health. COVID-19 Vaccine Planning for Fall. Winnipeg, MB: Manitoba Health; 2022. https://manitoba.ca/asset_library/en/proactive/20222023/covid-19-for-fall-en.pdf</Citation></Reference><Reference><Citation>Impact Canada. COVID-19 Snapshot Monitoring. 2022. [Accessed 2024 Mar 28]. https://impact.canada.ca/en/cosmo-canada</Citation></Reference><Reference><Citation>Galanis P, Vraka I, Katsiroumpa A, Siskou O, Konstantakopoulou O, Katsoulas T, Mariolis-Sapsakos T, Kaitelidou D. First COVID-19 booster dose in the general population: A systematic review and meta-analysis of willingness and its predictors. Vaccines (Basel) 2022;10(7):1097. 10.3390/vaccines10071097</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10071097</ArticleId><ArticleId IdType="pmc">PMC9323526</ArticleId><ArticleId IdType="pubmed">35891260</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelmoneim SA, Sallam M, Hafez DM, Elrewany E, Mousli HM, Hammad EM, Elkhadry SW, Adam MF, Ghobashy AA, Naguib M, Nour El-Deen AE, Aji N, Ghazy RM. COVID-19 vaccine booster dose acceptance: systematic review and meta-analysis. Trop Med Infect Dis 2022;7(10):298. 10.3390/tropicalmed7100298</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/tropicalmed7100298</ArticleId><ArticleId IdType="pmc">PMC9611447</ArticleId><ArticleId IdType="pubmed">36288039</ArticleId></ArticleIdList></Reference><Reference><Citation>Limbu YB, Huhmann BA. Why some people are hesitant to receive COVID-19 boosters: A systematic review. Trop Med Infect Dis 2023;8(3):159. 10.3390/tropicalmed8030159</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/tropicalmed8030159</ArticleId><ArticleId IdType="pmc">PMC10054177</ArticleId><ArticleId IdType="pubmed">36977160</ArticleId></ArticleIdList></Reference><Reference><Citation>McKinley CJ, Limbu Y. Promoter or barrier? Assessing how social media predicts Covid-19 vaccine acceptance and hesitancy: A systematic review of primary series and booster vaccine investigations. Soc Sci Med 2024;340:116378. 10.1016/j.socscimed.2023.116378</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2023.116378</ArticleId><ArticleId IdType="pubmed">38042027</ArticleId></ArticleIdList></Reference><Reference><Citation>Humble RM, Sell H, Wilson S, Sadarangani M, Bettinger JA, Meyer SB, Dubé È, Lemaire-Paquette S, Gagneur A, MacDonald SE. Parents’ perceptions on COVID-19 vaccination as the new routine for their children ≤ 11 years old. Prev Med 2022;161:107125. 10.1016/j.ypmed.2022.107125</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ypmed.2022.107125</ArticleId><ArticleId IdType="pmc">PMC9250244</ArticleId><ArticleId IdType="pubmed">35792197</ArticleId></ArticleIdList></Reference><Reference><Citation>Stehlin F, Khoudja RY, Al-Otaibi I, ALMuhizi F, Fein M, Gilbert L, Tsoukas C, Ben-Shoshan M, Copaescu AM, Isabwe GA. COVID-19 booster vaccine acceptance following allergy evaluation in individuals with allergies. J Allergy Clin Immunol Pract 2024;12(1):242–245.e2. 10.1016/j.jaip.2023.09.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2023.09.037</ArticleId><ArticleId IdType="pubmed">37802251</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali F, Kaura A, Russell C, Bonn M, Bruneau J, Dasgupta N, Imtiaz S, Martel-Laferrière V, Rehm J, Shahin R, Elton-Marshall T. Identifying barriers and facilitators to COVID-19 vaccination uptake among People Who Use Drugs in Canada: a National Qualitative Study. Harm Reduct J 2023;20(1):99. 10.1186/s12954-023-00826-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12954-023-00826-6</ArticleId><ArticleId IdType="pmc">PMC10387201</ArticleId><ArticleId IdType="pubmed">37516836</ArticleId></ArticleIdList></Reference><Reference><Citation>Public Health Agency of Canada. Evergreen Rapid Review on COVID-19 Vaccine Attitudes and Uptake in Canada - Update 11. Ottawa, ON: PHAC; 2021. https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/canadas-reponse/summaries-recent-evidence/evergreen-rapid-review-vaccine-attitudes-uptake-update-11.html</Citation></Reference><Reference><Citation>Léger C, Deslauriers F, Gosselin Boucher V, Phillips M, Bacon SL, Lavoie KL. Prevalence and motivators of getting a COVID-19 booster vaccine in Canada: results from the iCARE study. Vaccines (Basel) 2023;11(2):291. 10.3390/vaccines11020291</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11020291</ArticleId><ArticleId IdType="pmc">PMC9960725</ArticleId><ArticleId IdType="pubmed">36851169</ArticleId></ArticleIdList></Reference><Reference><Citation>Leigh JP, FitzGerald EA, Moss SJ, Brundin-Mather R, Dodds A, Stelfox HT, Dubé È, Fiest KM, Halperin D, Ahmed SB, MacDonald SE, Straus SE, Manca T, Kamstra JN, Soo A, Longmore S, Kupsch S, Sept B, Halperin S. Factors affecting hesitancy toward COVID-19 vaccine booster doses in Canada: a cross-national survey. Can J Public Health 2024;115(1):26–39. 10.17269/s41997-023-00823-z</Citation><ArticleIdList><ArticleId IdType="doi">10.17269/s41997-023-00823-z</ArticleId><ArticleId IdType="pmc">PMC10853155</ArticleId><ArticleId IdType="pubmed">37991692</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu P, Tatar O, Haward B, Steck V, Griffin-Mathieu G, Perez S, Dubé È, Zimet G, Rosberger Z. Examining an altruism-eliciting video intervention to increase COVID-19 vaccine intentions in younger adults: A qualitative assessment using the realistic evaluation framework. Vaccines (Basel) 2023;11(3):628. 10.3390/vaccines11030628</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11030628</ArticleId><ArticleId IdType="pmc">PMC10056235</ArticleId><ArticleId IdType="pubmed">36992212</ArticleId></ArticleIdList></Reference><Reference><Citation>IPSOS. BC Booster Shots: Fewer than Half (44%) of British Columbians with Two Doses of a COVID-19 Vaccine Plan to Get Their Booster Shot as Soon as Available. Vancouver, BC: IPSOS; 2022. https://www.ipsos.com/sites/default/files/ct/news/documents/2022-02/BCPhA_Boosters-Factum-2022-02-09-v1_2.pdf</Citation></Reference><Reference><Citation>Ayyalasomayajula S, Dhawan A, Karattuthodi MS, Thorakkattil SA, Abdulsalim S, Elnaem MH, Sridhar S, Unnikrishnan MK. A systematic review on sociodemographic, financial and psychological factors associated with COVID-19 vaccine booster hesitancy among adult population. Vaccines (Basel) 2023;11(3):623. 10.3390/vaccines11030623</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11030623</ArticleId><ArticleId IdType="pmc">PMC10051942</ArticleId><ArticleId IdType="pubmed">36992207</ArticleId></ArticleIdList></Reference><Reference><Citation>Yazdani Y, Pai P, Sayfi S, Mohammadi A, Perdes S, Spitzer D, Fabreau GE, Pottie K. Predictors of COVID-19 vaccine acceptability among refugees and other migrant populations: A systematic scoping review. medRxiv 2023. [Accessed 2024 Mar 28]. 10.1101/2023.09.15.2329560810.1101/2023.09.15.23295608</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.09.15.23295608</ArticleId><ArticleId IdType="doi">10.1101/2023.09.15.23295608</ArticleId><ArticleId IdType="pmc">PMC11226018</ArticleId><ArticleId IdType="pubmed">38968187</ArticleId></ArticleIdList></Reference><Reference><Citation>Limbu YB, Gautam RK. How well the constructs of health belief model predict vaccination intention: A systematic review on COVID-19 primary series and booster vaccines. Vaccines (Basel) 2023;11(4):816. 10.3390/vaccines11040816</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11040816</ArticleId><ArticleId IdType="pmc">PMC10141697</ArticleId><ArticleId IdType="pubmed">37112728</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzenios N, Tazanios ME, Chahine M. Combining influenza and COVID-19 booster vaccination strategy to improve vaccination uptake necessary for managing the health pandemic: A systematic review and meta-analysis. Vaccines (Basel) 2022;11(1):16. 10.3390/vaccines11010016</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11010016</ArticleId><ArticleId IdType="pmc">PMC9860577</ArticleId><ArticleId IdType="pubmed">36679863</ArticleId></ArticleIdList></Reference><Reference><Citation>Leger. North American Tracker - January 10th, 2022. 2022. https://leger360.com/wp-content/uploads/2024/02/Legers-North-American-Tracker-January-10th-2022_V2.pdf</Citation></Reference><Reference><Citation>Government of Canada. Childhood COVID-19 Immunization Coverage Survey (CCICS): 2022 results. Ottawa, ON: Government of Canada; 2023. https://www.canada.ca/en/public-health/services/immunization-vaccines/vaccination-coverage/childhood-covid-19-immunization-coverage-survey-2022-results.html</Citation></Reference><Reference><Citation>Angus Reid Institute. Omicron Inevitability? 55% say they’ll be infected regardless of precautions; two-in-five would end all restrictions. 2022. https://angusreid.org/wp-content/uploads/2022/01/2022.01.13_COVID_inevitability.pdf</Citation></Reference><Reference><Citation>Angus Reid Institute. Unconcerned about Omicron: More than four-in-five now believe a COVID-19 infection would be mild, manageable. 2022. https://angusreid.org/wp-content/uploads/2022/01/2022.01.26_COVID_Unconcerned_about_Omicron.pdf</Citation></Reference><Reference><Citation>Thaivalappil A, Young I, MacKay M, Pearl DL, Papadopoulos A. A qualitative study exploring healthcare providers’ and trainees’ barriers to COVID-19 and influenza vaccine uptake. Health Psychol Behav Med 2022;10(1):695–712. 10.1080/21642850.2022.2106231</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21642850.2022.2106231</ArticleId><ArticleId IdType="pmc">PMC9359157</ArticleId><ArticleId IdType="pubmed">35957955</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee S, Hunter A, John P, Koenig R, Lee-Whiting B, Loewen P, McAndrews J, Nyhan B, Savani M. Thinking about default enrollment lowers vaccination intentions and public support in G7 countries. PNAS Nexus 2024;3(4):093. https://academic.oup.com/pnasnexus/article/3/4/pgae093/7614389</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10997051</ArticleId><ArticleId IdType="pubmed">38585340</ArticleId></ArticleIdList></Reference><Reference><Citation>Government of Canada. Evidence brief on attitudes and acceptance of COVID-19 booster doses. Ottawa, ON: Government of Canada; 2022. https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/canadas-reponse/summaries-recent-evidence/evidence-brief-attitudes-acceptance-covid-19-booster-doses.html</Citation></Reference><Reference><Citation>Canadian Institute for Health Information. Canadian Data Set of COVID-19 Interventions - Data Tables. Ottawa, ON: CIHI; 2022. [Accessed 2024 Aug 13]. https://www.cihi.ca/en/canadian-covid-19-intervention-timeline</Citation></Reference><Reference><Citation>Institut national de santé publique du Québec. Administration de doses de rappel du vaccin contre la COVID-19: recommandations pour l’automne 2023. Québec, QC: INSPQ; 2023. https://www.inspq.qc.ca/publications/3367</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>